Teamworthy Ventures — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Drug Hunter publishes educational content, molecule case studies, patent highlights, and analysis on small molecule and biologic drug discovery for medicinal chemists and pharmaceutical R&D professionals.
BiotechHealthtechMedia & EntertainmentPortland, US
Dennis X. Hu(Executive Officer, Director, Promoter)
Board seatThomas Lehrman· per SEC Form D
Co-investorsFCA Venture Partners
GovWorx builds AI-powered software for 9-1-1 emergency communications centers, covering call quality assurance, candidate assessment and hiring, leadership promotion, call and radio simulation training, and real-time policy-driven call guidance and translation.
AI & Machine LearningGovTechSaaSDenver, US
Scott MacDonald(Executive Officer, Director)inAlexander Henry Montgomery(Executive Officer, Director)
BoardChris Maloney(Director)Stewart Lynn(Director)
Board seatStephen Schmalhofer· per SEC Form D
Chicago, US
Nikolas Cromydas(Executive Officer, Director)
BoardDave Knox(Director)Brian Reinken(Director)Jamie Gilpin(Director)
Board seatStephen Schmalhofer· per SEC Form D · $8M raise · filed Mar 2025
Co-investorsFJ LabsNetwork Ventures
New York, US
Jeremy Baksht(Executive Officer, Director, Promoter)Travis May(Executive Officer, Director)
Co-investorsFloating PointBlue MoonLiquid VenturesSpringTime Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.